[1]
Yulistiani, H. Izka A, M. Rindang A, and P. A W, “IAI SPECIAL EDITION: Tocilizumab therapy in COVID-19 patients”, Pharm Educ, vol. 22, no. 2, pp. p. 259–262, Mar. 2022.